Marianna Wonder

Marianna Wonder

Cadwalader, Wickersham & Taft LLP

Contact
View Bio
RSS

Latest Posts › Fresenius

Share:

M&A Update: Akorn Falls Far from the Tree: Delaware Chancery Court Finds a “Material Adverse Effect” for the First Time in Akorn,...

On October 1, 2018, the Delaware Court of Chancery found in Akorn, Inc. v. Fresenius Kabi AG, et al. that Fresenius was entitled to terminate its merger agreement with Akorn. ...more

10/26/2018  /  Contract Termination , EBITDA , Food and Drug Administration (FDA) , Fresenius , Material Adverse Effects , Merger Agreements , Pharmaceutical Industry , Representations and Warranties
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide